These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1673628)

  • 21. Puerperal lactation suppression and prolactin.
    De Gezelle H; Dhont M; Thiery M; Parewyck W
    Acta Obstet Gynecol Scand; 1979; 58(5):469-72. PubMed ID: 394563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of lactation by cyclofenil and bromocriptine.
    Thorbert G; Akerlund M
    Br J Obstet Gynaecol; 1983 Aug; 90(8):739-42. PubMed ID: 6411113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CV 205-502 in acromegaly.
    Chiodini PG; Attanasio R; Cozzi R; Dallabonzana D; Oppizzi G; Orlandi P; Strada S; Liuzzi A
    Acta Endocrinol (Copenh); 1993 May; 128(5):389-93. PubMed ID: 8100375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.
    Giorda G; de Vincentiis S; Motta T; Casazza S; Fadin M; D'Alberton A
    Gynecol Obstet Invest; 1991; 31(2):93-6. PubMed ID: 2037265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of several sexual steroids, 2-bromo-ergokryptin and lisurid-hydrogenmaleate an the postpartum concentration of serum prolactin and lactation (author's transl)].
    Schmidt-Gollwitzer M; Hardt W; Schmidt-Gollwitzer K; Michel E; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Jun; 37(6):500-8. PubMed ID: 328335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dostinex - the most effective medicine for inhibition of postpartal lactation].
    Bozhinova S; Porozhanova V; Penkov V
    Akush Ginekol (Sofiia); 2001; 40(4):11-4. PubMed ID: 11803861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dihydroergocristine in stopping lactation: double-blind study vs bromocriptine.
    de Aloysio D; Pamparana F; Zanotti A; Fabiani AG; Bottiglioni F
    Gynecol Endocrinol; 1988 Mar; 2(1):67-71. PubMed ID: 3140592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbohydrate tolerance in the puerperium during suppression of lactation with bromocriptine and oestrogens.
    Peters FD; Roemer VM
    Br J Obstet Gynaecol; 1977 Jul; 84(7):531-3. PubMed ID: 911711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of puerperal lactation by bromocriptine.
    Rolland R; Schellekens LA
    Acta Endocrinol Suppl (Copenh); 1978; 216():119-30. PubMed ID: 347857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of bromocriptine-intolerant prolactinoma patients with CV 205-502.
    Glaser B; Nesher Y; Barziliai S
    J Reprod Med; 1994 Jun; 39(6):449-54. PubMed ID: 7932398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in carbohydrate tolerance in the puerperium by inhibition of lactation with bromocriptine and quinestrol (author's transl)].
    Peters FD; Roemer VM
    Arch Gynakol; 1977 Sep; 223(2):93-7. PubMed ID: 578680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of bromocriptine on mammary development and function in lactating mice.
    Knight CH; Calvert DT; Flint DJ
    J Endocrinol; 1986 Aug; 110(2):263-70. PubMed ID: 3746163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of prolactinoma with a new dopamine agonist].
    Svoboda T; Luger A; Knosp E; Geyer G
    Dtsch Med Wochenschr; 1991 Aug; 116(33):1224-7. PubMed ID: 1678695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of the suppression of lactation and the influence on blood clotting with bromocriptine (CB 154) (Parlodel): a double blind comparison with diethylstilboestrol.
    Nilsen PA; Meling AB; Abildgaard U
    Acta Obstet Gynecol Scand; 1976; 55(1):39-44. PubMed ID: 766555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effectiveness, safety, and tolerability of CV 205-502 in hyperprolactinemic women: a 12-month study.
    van der Heijden PF; Lappöhn RE; Corbey RS; de Goeij WB; Brownell J; Rolland R
    Fertil Steril; 1989 Oct; 52(4):574-9. PubMed ID: 2806597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of bromocriptine and chlorotrianisene on inhibition of lactation and serum prolactin. A comparative double-blind study.
    Utian WH; Begg G; Vinik AI; Paul M; Shuman L
    Br J Obstet Gynaecol; 1975 Sep; 82(9):755-9. PubMed ID: 1101946
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum prolactin and the suppression of lactation.
    Weinstein D; Ben-David M; Polishuk WZ
    Br J Obstet Gynaecol; 1976 Sep; 83(9):679-82. PubMed ID: 788774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of lactation. A comparison of bromocriptine and prostaglandin E2.
    England MJ; Tjallinks A; Hofmeyr J; Harber J
    J Reprod Med; 1988 Jul; 33(7):630-2. PubMed ID: 3172062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine given orally to periparturient of lactating sows inhibits milk production.
    Farmer C; Robert S; Rushen J
    J Anim Sci; 1998 Mar; 76(3):750-7. PubMed ID: 9535334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.